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One of the long-expected goals of genome-scale metabolic modeling is to evaluate the 
influence of the perturbed enzymes to the flux distribution. Both ordinary differential 
equation (ODE) models and the constraint-based models, like Flux balance analysis (FBA), 
lack of the room of performing metabolic control analysis (MCA) for large-scale networks. In 
this study, we developed a Hyper-Cube Shrink Algorithm (HCSA) to incorporate the 
enzymatic properties to the FBA model by introducing a pseudo reaction constrained by 
enzymatic parameters. Our algorithm was able to handle not only prediction of knockout 
strains but also strains with quantitative adjustment of expression level or activity. We first 
demonstrate the concept by applying HCSA to a simplest three-node network. Then we 
validate its prediction by comparing with ODE and with a synthetic network in 
Saccharomyces cerevisiae producing voilacein and analogues. Finally we show its capability 
of predicting the flux distribution in genome-scale networks by applying it to the sporulation 
in yeast.  
 
Introduction 
 
One of the major part of current system biology in the –omics era is developing 
genome-scale models. Integrating various data sets to achieve overall and precise 
modeling of metabolism and thus predicting the consequences upon genetic 
perturbations or small molecules’ inhibition is one of the major goals. Given the 
complexity of enzymatic reactions and high dimensionality of metabolic networks, such 
goal remains a challenging task using the ordinary differential equation approach. On 
the other hand, under the premise that biochemical networks are evolutionary optimal 
to maximize their growth rate or other end product production, Flux Balance Analysis 
(FBA) predicts testable flux distribution at steady state based on only stoichiometric 
numbers under the framework of linear programing1,2.This modeling overcome the scale 
difficulties and precisely predicted the essentiality of enzymes. The genome-scale 
models, including E. coli1, yeast2,3, rodent4 and human5 etc, have been built up and well 
curated6. In FBA, constraint that metabolic networks are at a steady state is imposed by 
stoichiometry in a biochemical network. For a network that includes ݉ metabolites and 
݊ reactions, the sum of production and consumption fluxes of each internal metabolites, 
weighted by the corresponding stoichiometry coefficient, is zero: ܵ ∙ ݒ = 0, ܵ is the 
݉ × ݊ stoichiometric matrix and ݒ is the fluxes.  
 
Though FBA succeeded in predicting the essentiality of genes and the maximum 
evolution capacity under rare carbon source like glycerol7, its limitation is tremendous. 
First, the optimality assumption engendered through evolutionary pressure could be 
invalid for engineered strains or other strains that haven’t experienced such selections. 
Second, lack of the parameters of enzymes hindered us to perform MCA. Thus we were 
not able to predict the consequences of perturbed enzymes.  
 
To incorporate the enzymatic information to the constraint-based model, the Boolean 
on/off constraints have been imposed to the network by cutting off the transcriptional 
level of enzymes8. As an improved implementation, iMAT9,10 and MPA11 have been 
developed to estimate the phenotypes using enzyme expression data as cues. Still, the 
expression of enzymes was used as discrete states (high level, median level and low 
level). The mixed integer linear programming (MILP) has been employed to find out the 
most likely consistency between expression and flux states (either < ߝ  or > ߝ ). 
However, the threshold of the expression level is arbitrary and it is qualitative rather 
than quantitative. If the algorithm of incorporating the enzyme’s abundance 
quantitatively exists, then one would be able to calculate the influence of stepwise 
change of each enzyme to all fluxes. Such information may be used to improve the yield 
of the end products or find out the drug targets for curing diseases, such as diabetes 
mellitus and cancers etc. The action matrix of enzyme deletions versus all fluxes would 
also be regressed to the corresponding phenotype vector and then the key reactions 
determined this phenotype would be revealed.  
 
To solve this problem, we herein developed a Hyper-Cube Shrink Algorithm (HCSA) to 
find an interior point that is uniquely defined by the enzyme profile. Instead of using 
biomass as the objective function, we formulated a pseudo-reshaping flux whose 
maximum value defines the minimum volume of a hyper cube, which intersect original 
solution space at a single point. We succeeded in not only reducing the complexities but 
also retained some key features of Michaelis–Menten system.  
 
First, we demonstrate the algorithm using a simplest three-node network. Second, we 
compared the its ability with ODE models in a six-reaction network. Third, we compared 
the prediction with experimental results in voilacein pathway. Finally, we applied it in 
genome-scale networks in the sporulation of budding yeast, Saccharomyces cerevisiae. 
We gave a reasonable overall estimation of amino acids synthesis in eighteen time points 
and found the potential rate-limiting enzymes in different time points.  
 
Results 
The Formula of Hyper-Cube Shrink Algorithm 
We used a row vector to express this N-dimensional set of parameters, named Enzyme 
Distribution Vector (EDV), which is a key input for our linear model to include dynamical 
consideration and achieves a high correlation between proteins and flux. The 
N-dimensional flux distribution vector (FDV) is output of HCSA, playing the role as a 
straightforward readout of cellular functional state under a specific transcriptional state. 
Our goal is to heal the gap between transcriptional data and testable network phenotypes. 
Mathematically it is a mapping from EDV ( ௘ܸ) to FDV ( ௙ܸ). The problem is to find out the right 
solution from the space defined by ܵ ∙ ݒ =  0 plus extra constraints, like the reversibility or 
maximum uptake flux of nutrients etc. In FBA, the biomass flux was optimized based on the 
assumption that microbes were evolved to grow fast in a competitive environment. Herein, 
we constructed a pseudo flux ܸ as the objective function, which defines a hyper cube that 
shrinks while maximizing the matching of FDV and EDV along the increase of ܸ. Besides the 
steady state equality constraint mentioned above, pairs of inequality constraints are set to 
FDVs, in the form: 
݈௜ + ܥ௜ܸ ≤ ݒ௜ ≤ ݑ௜ − (1 − ܥ௜)ܸ         (1) 
ݒ௜ (ܥ௜) is the ݅th component of FDV (EDV), ݑ௜ is the upper bound of reaction ݅. Here is 
HCSA in standard formula of LP problem:  
݉ܽݔ݅݉݅ݖ݁ ܸ ݏ. ݐ. 
[ܵ௠×௡ 0௠×ଵ] ቂ
ݒ௡×ଵ
ଵܸ×ଵ ቃ = 0(௡ାଵ)×ଵ   (2) 
൤−ܫ௡×௡ ܥ௡×ଵܫ௡×௡ 1௡×ଵ − ܥ௡×ଵ൨ ቂ
ݒ௡×ଵ
ଵܸ×ଵ ቃ ≤ ൤
0௡×ଵ
1௡×ଵ൨  (3) 
ݒ௜ ∈ [ܮ௜ ௜ܷ] 
 
Started with original FBA formula (the solution space is the blue triangle in Figure 1A), we 
added two pseudo metabolites implemented by equation (3) to each reaction to restraint the 
dynamic lower and upper bound. All the pseudo metabolites were coordinated by a pseudo 
reaction ܸ, where the coefficients (ܥ௜) of pseudo metabolites in ܸ are the normalized 
abundance of each enzyme. When ܸ varies from 0 to ݉ܽݔ ܸ, it defines hyper cube 
shrinkage (as shown in Figure 1F-G). The vertex of the cube closest to the origin moves at the 
speed defines by ܥ௜ along each axis. The solution space for the entire problem is thus the 
cross-section between the hyper cube and polyhedron defined by original FBA.  
 
We use the three-reaction toy model (Figure 1A) to show the concept. The equality and 
inequality constraints define a feasible space ߔ  in N-dimensional vector space 
collaboratively. ߔ is an intersection of a polyhedron (Figure 1B) and a hyper cube (Figure 1C) 
whose volume is shrinking as the problem solver finds a higher and higher value of the 
formal parameter ܸ (yellow triangle in Figure 1F). Although not proven, ߔ shrinks to a 
single point when V takes its maximum value (Figure 1G), since the edges of hyper cube are 
parallel to coordinate axis and the polyhedron is an oblique one which passes through the 
origin. It is noteworthy to remark that FDV is a balanced solution for the steady state of 
metabolic network and our EDV is outside ߔ mathematically.  
 
We show a solution ܨܦܸ =  [1 5/9 4/9] of the toy model for ܧܦܸ =  [8 5 4] as shown in 
Figure 1H. We obtained a FDV well correlated with EDV as shown in Figure 1I. The 
visualization of HSCA was shown in Supplementary Movie 1. We also varied EDV(2) from 0.5 
to 5, followed by varying EDV(3) from 4 to 0.4. The phase transition curve of this change was 
shown in supplementary Figure 1 and supplementary Movie 2.  
 
A similar enzymatic dose response behavior compared with ODE model 
With the Kୡୟ୲ implied in the model, we were able to simulate the network for different 
enzyme expression levels. To test the performance of HCSA, we used ordinary differential 
equation to model the six-reaction network, characterized by Michaelis constants (K୫’s) and 
catalytic rate constant (kୡୟ୲’s) of the enzymes. We varied the enzyme amount to the same 
extent in both models to compare the FDVs.  
 
One of the main functions of our algorithm is its ability of dealing with the variation of 
enzyme expression levels. And considering the amount of enzyme will significantly influence 
the dynamic interaction between substrates and enzymes, we built a concise ODE model to 
test HCSA. The ODE system consists of six biological reactions, and all of them are supposed 
to be Michaelis–Menten ones, irreversible. Each enzyme was given a unique kୡୟ୲ − ܭ௠ 
combination (See supplementary Table I). Each time we altered one of enzyme amounts in 
ODE model to simulate a regulation of gene expression, and modify the corresponding 
component in EDV proportionally. The amounts of enzymes that catalyze number 2, 4, 6 
reactions varied by fold from 0.1 to 10 (Figure 2A-C). The norm of six simulated FDVs are 
normalized to one so as to show the relative magnitudes of six flux are predicted in the same 
pattern in these two kinds of models, the shape of curves generated by ODE and HCSA were 
perfectly matched (Figure 2D-I). Overall, 77% of curves have correlation coefficients over 
0.99(Figure 2J-L).  
 
There is a scenario can be easily imaged. When the downstream enzymes were up-regulated 
to very high level, the flux of this branch will asymptotically approach to a limit number 
because of the bottleneck effect of upstream enzymes. Indeed, we observed this 
phenomenon under both frameworks (Figure 2D-I). And the excess of an enzyme leads to 
“substrate saturation”. If we calculate the ∆ݒ/∆ܧ for each change pair, this ratio is always 
less than unit. It means the network is always resistant to enzyme perturbations, implying 
the system is robust. Our HCSA has captured this feature in essence.  
 
Real biological dynamic networks might contain reversible reactions or allosteric feedback 
terms thus have a modified ܭ௠ , but our simulation showed that the strong positive 
correlation still exists, as shown in supplementary Figure 2. Much of our algorithm’s 
prediction ability is attributed to its good consistency with classic ODE model, which gives it 
foundation to work with empirical subjects effectively. 
 
Prediction of flux distribution in violacein biosynthesis pathway in Saccharomyces 
cerevisiae 
We applied our model to the violacein pathway in Saccharomyces cerevisiae to test its efficacy. 
As described previously, this branch of metabolic network includes nine metabolites, six 
enzyme catalyzed steps and two non-enzymatic reactions12,13, as shown in Figure 3A. A set of 
promoters (pTDH3, pTEF1, pRPL18B, pRNR2 and pREV1) is used to regulate the expression 
level of the five key enzymes - VioA, VioB, VioC, VioD and VioE. The five promoters were able 
to produce a wide range of expression levels change. 191 samples of the expression library 
were used and their promoter genotypes are identified using TRAC12. HPLC analysis was 
employed to measure the pathway products, from which the flux distribution could be 
uniquely determined.  
 
Such a promoter combination provides both a challenge for a computational model and a 
good opportunity to reveal its power. We use 7% (14 of 191) data groups as training sets and 
the rest for testing. Each time a promoter combination is chosen, and the strength of the 
promoters directs us to modify the components of the datum quantitatively, representing the 
fold change of gene expression level. And HCSA was employed to calculate ratios of the eight 
flux' magnitude were obtained, see supplementary text for details.  
 
The absolute amplitude of the flux of the entire branch is determined by the enzyme 
expression of the first three reactions and their cross product. We used a multiple regression 
model to predict it, as shown in supplementary text and Figure 2. The parameters of this 
model were obtained through the training set. The ratios from HCSA multiply the amplitude 
gave us the final flux. We obtained very good consistency between HCSA simulation and 
measured flux. The result is visualized in Figure 3B – 3E, and the square of correlation 
coefficient is 0.76, 0.72, 0.51 and 0.84 for violacein, deoxyviolacein, proviolacein and 
prodeoxyviolacein respectively, as shown in Figure 3.  
 
We were also curious about if we are able to validate the saturation curves in Figure 2D - 2I. 
Some single-variable subsets of experimental data were screened out. And here we choose 
one in which only enzyme VioD varies, whose expression level was modified throughout a 
range of almost one thousand folds This wide range of regulation results in a dramatic 
increase in production of violacein and proviolacein as well as a drop in the other two 
primary products. It looks like a seesaw was pulled up at one end causing pushed down at 
the other end. This redistribution of flux follows a “Seesaw” like mechanism, as shown in 
supplementary Figure 4. We noticed the saturation behavior mentioned before appeared 
again in both the experimental data and our simulation flux data, which means HCSA 
captured the key characteristics.  
 
Genome-scale network implementation of HCSA 
When the network was scaled up to genome-scale, we wanted to test if HCSA is still 
applicable. Here we chose Yeast iND7503 as the model system. We used the ribosomal 
profiling data performed by Brar et. al14 during the time course of meiosis, which occurs 
when diploid yeast cells were incubated in poor media and low temperature. The ribosomal 
profiling data covered 21 different time points at different stages of sporulation.  
 
HCSA gets more reasonable flux distribution compared to conversional methods 
We first compared the results obtained by FBA and HCSA in normal growth condition. In this 
analysis, we kept the biomass flux and restricted it in a reasonable range (0.3~maxflux). 
Then we maximized the pseudo flux V. We compared the results with previous measured flux 
by Moxley et. al15 in yeast. Among 77 reactions with experimentally measured fluxes, 51 
non-zero-fluxes have been obtained by FBA and 64 non-zeros have been obtained by HCSA. 
For instance, in FBA threonine synthesis has been catalyzed through glycine + acetaldehyde 
 L-threonine by Gly1, of which the specificity is too low to occur experimentally. In HCSA, 
the normal threonine synthetic pathway has been chosen according to the expression level. 
Other different reaction sets were listed in Supplementary Table IV. Using experimental 
fluxes as the reference, the correlation coefficient with HCSA fluxes and FBA fluxes are very 
similar (0.81 versus 0.81), while HCSA flux has a smaller p-value because it has more 
non-zero data points (1݁ିଵହ versus 3݁ିଵଷ).  
 
HCSA predicts correct yields of end product 
In HCSA, the fluxes were determined by enzyme abundances. The biomass flux was thus not 
necessary. We split the biomass flux into 43 outflow reactions and used 0.5 as the pseudo 
expression level for all of them. After maximizing V, we obtained their outgoing rate, as 
shown in Figure 4A. The yield of biomass precursors correlated very well (ݎଶ  =  0.81 in log 
scale, as shown in Figure 4A) with their corresponding biomass coefficient that determined 
from dry mass of yeast.  
 
Simulate flux from ribosomal profiles during sporulation 
FBA does not need the abundance data and the kinetic parameters. It was an advantage 
when all these data are missing. But now it’s a shortcoming for taking advantage of 
genome-scale data. Covert et al developed an algorithm to cut the abundance data with a 
threshold then applied a Boolean constraint in FBA model16. In sporulation, a cell 
transformed to four spores but and did not grow in volume thus one could not optimize the 
biomass to obtain the EDV. We used the ribosomal profiling data measured by Brar et. al14. 
We first changed the medium conditions, including shutting off glucose uptake flux, turning 
on acetate uptake reaction and opening amino acids uptake reaction to the amount less than 
biomass coefficient. We split the biomass flux to subgroups, including a.a. (amino acids)  
synthetic reactions (consist of 20 amino acids using the coefficients same as in biomass), 
nucleotide synthetic reactions (consist of 4 nucleotides) and others (individual output flux 
or single metabolite). The EDV for a.a. flux was set to NULL so that this flux will be 
determined by relative enzymes rather than uptaken directly from the medium. We 
embedded the EDVs in various sporulation stages to virtual V and obtained corresponding 
FDVs.  
 
The uneven expression profiles (Figure 4B) was converted to even flux profiles (Figure 4C) 
by HCSA, indicating the balance of the metabolites had de-noise effect. The median curve of 
EDVs showed four up-regulation peaks, which means the cells surfers continuous amino 
acids starvation.  
 
The combined amino acid reaction showed a continuous trend during the entire sporulation 
(Figure 4D, red curve). The average expression level increased by ~4 folds, yield 2 folds 
increase of synthetic flux at time point E. The a.a. flux then decreased gradually until the 
lowest point K. At this point, cells were at the very beginning of metaphase I. After that a.a. 
flux increased gradually through metaphase I, anaphase I, metaphase II, anaphase II until 
spore formation.  
 
By comparing the median EDV curve and a.a. flux curve in Figure 4D, we observed that when 
the median EDV just started to be up-regulated, the a.a. flux didn’t response immediately 
(blue drop lines). In the latter part of the two curves, the efficacy ௔ܸ௔/ܧ increased, showing 
the coordination between different pathways yield more efficient overall flux.  
 
Hom6 might be the rate-limiting enzyme 
 
MCA exposed the casual relationship between enzymes’ abundance and fluxes. Because the 
abundance of enzyme were embedded in the model, we were able to calculate the metabolic 
control coefficient, which is defined as ߛ௜ = ∆ݒ/∆ܧ. The full metabolic control coefficient 
matrix Υ was visualized in Figure 5A. We found two genes catalyzing three reactions have 
positive ߛ௜, which means increasing ܧ௜ cause increased a.a. flux. Taking time point B as the 
starting point, increase Hom6 and Gly1 by 1.2 fold was able to increase a.a. flux by 1.1 and 
1.03 folds respectively, as shown in Figure 5A, column 2 row 1~3. Across all the conditions, 
Hom6 (catalyzing HSDyi & HSDxi) and Gly1 (catalyzing THRA) possess most positive ߛ. The 
control point in this figure means the enzyme is the rate-limiting step. One may expect that 
they all have low expression level. The expression level of these enzymes were shown in 
Figure 5B, we found most of these enzymes have been relatively high expressed, which 
means they are under tight regulation.  
 
From Figure 4D, we found the total enzyme expression decreased but the a.a. flux increased. 
In Figure 5B, DDPA, DDPAm, PPNDH, HISTP and PHETA1 decreased in the latter part. One 
possible explanation for this contradiction is that cells uptake more amino acids from the 
SPO media. As shown in Figure 5C, the uptake flux of PRO, PHE, MET, LYS, LEU and ILE 
increased significantly in the latter part.  
 
We also calculated the correlation between enzyme abundance data and the a.a. flux. The 
results were listed in supplementary Table VI. Hom6 has the best correlation (ݎଶ = 0.8) with 
a.a. flux among all the enzymes, the scatter plot is shown in supplementary Figure 5. It is 
noteworthy that not all the enzymes with good correlation have casual effect. The good 
correlation may come up with co-regulation. As shown in Figure 5A, we observed Hom6 has 
positive ߛ for eight times, meaning the result does not depend on the conditions.    
  
Discussion 
In this study, we developed an algorithm to incorporate enzyme information to the 
stoichiometric model, we call it hyper cube shrink algorithm (HCSA). Incorporation of 
enzyme activity is urgent for metabolic engineering and understanding / curing the 
metabolic disorder of diseases. In some genetically engineered bacterium strains, the 
expression of a specific enzyme can be quantitatively changed, which means we should 
adjust EDV quantitatively. This can not be done by FBA1,17 or MOMA18 because they can not 
handle the case of expression level modification. But this is what HCSA is for, interestingly, 
prediction of HCSA corresponds well with ODE models and experimental data in dynamic 
patterns.  
 
Previously, Integrative Metabolic Analysis Tool (iMAT)10 and IOMA19 have been developed to 
incorporate expression data to the models. iMAT uses mixed integer linear programming 
(MILP), which requires extensive parallel computing resources. It maximizes the number of 
reactions whose flux is consistent with their expression level. For both expression data and 
predicted flux, the values have been simplified to Boolean numbers. In contrast, we use the 
exact values as the estimation cues. The overall flux of a branch was determined by the 
combined effect of all the enzymes. Thus, we obtained more reasonable flux distributions. 
IOMA is formulated as a quadratic programming problem requiring proteomic and 
metabolomics data. It required the turnover rate of enzymes and thus limited its application.  
 
Another alternative method, CEF or mCEF20,21, has been developed based on the elementary 
modes (EM) of the network to solve the genetic modification problem. It uses quadratic 
programming to find out the linear combination of EMs to resemble the gene expression 
profile. It has the followed drawbacks. First, EM is hard to be computed for larger networks 
and requiring manually merging the reactions to reduce the computation burden. Second, its 
solution is not unique, thus it’s hard to compare the flux change upon enzyme changes. Third, 
it’s not very intuitively clear mathematically.  
 
Essentially, HCSA find a solution well correlated with fluxes, which is supported by 
experimental results. This correlation is not complete because of regulated enzyme kinetics. 
Thus, the expression data were just treated as cues for determining the metabolic flux of 
corresponding reactions. As the enzyme activity was treated as parameters in the model, the 
perturbed network can be easily simulated. Thus the metabolic control matrix was obtained. 
Further, relying on enzyme expression data to infer the metabolic flux eliminates the need of 
objective function. Rather, the effluxes can be predicted based on the EDV. Though not shown 
here, HSCA were easily be applied to large scale networks, like human network, which is 
comprised of more than 2000 reactions.  
 
There are still some inconsistency between our prediction value and the empirical curve in 
Figure 3, which indicates the existence of some secondary interactions between enzymes 
and metabolites. The inconsistency between our prediction and the experimental data also 
comes from the intrinsic property of the promoters22,23. The scatter plot of RNA level versus 
protein level bears similar shape24. This phenomenon calls for an improvement of HCSA if 
one asks for more precise predictions. At the same time, it also interprets HCSA’s power to 
tolerate inclusion of relatively trivial data when people are working on pathways with only 
incomplete knowledge.  
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Figure 1. (A) – (F) Take a one-node metabolite network as an extremely simplified example 
to illustrate the optimization principle underlying HCSA. (B) The solution space constrained 
by ݒଵ = ݒଶ + ݒଷ  is within a plane (colored blue). (C)- (F) The direction of EDV is 
represented by a red arrow, showing how the lower bounds of fluxes increase. The direction 
of the black arrow shows how upper bounds decrease. Geometrically, the magnitudes of both 
arrows are proportional to the magnitude of pseudo reaction V and the orange cube is 
uniquely determined by them. (C) The state in which the value of objective function is still 
far below maximum. (D) The feasible solution space is defined as the intersection of the 
plane and cube (yellow triangle). (E) When objective function reaches its optimum, the 
length of two arrows reach maximum and the cube becomes smallest. So all the candidate 
points in it uniformly have a strong correlation to the EDV vector. (F) The optimal solution, 
FDV, is the single point still in the intersection of flux balance plane and the hyper cube. (G) 
Analysis of the optimum state in terms of the three coordinates respectively. The light green 
segments rebuild the spatial cube and the components of FDV lie either on the upper bounds 
or the lower bounds. (H) A strong correlation between the enzyme parameters and flux 
distributions is indeed established by HCSA. 
 
Figure 2. The comparison of HCSA and ODE model on a branch-like metabolic network. (A) – 
(C) The topology of the network, thick arrow indicates the flux whose enzyme parameter 
uniquely varies. (D)- (F) The dose response of fluxes upon enzymes changes from 10-1 to 101 
for reaction 2, 4, 6, simulated by HSCA. When the enzymes are at low concentration, the 
fluxes are linearly correlated with enzymes. When the enzyme is over dosed, the flux 
approaches to an asymptotic value. (G)- (I) The curves simulated by ODE model. (J)- (L) The 
comparison of ODE and HCSA fluxes predictions in which over 77% of results have 
correlation coefficients over 0.99. 
 
Figure 3. Application of HCSA to quantitatively predict flux distribution in violacein pathway. 
(A) The violacein biosynthetic pathway in Saccharomyces cerevisiae. It’s a metabolic network 
consists of 6 enzymatic and 2 non-enzymatic reactions. L-Trp, L-Tryptophan; PDVA, 
protodeoxyviolaceinic acid; PVA, protoviolaceinic acid; PDV, prodeoxyviolacein; DV, 
deoxyviolacein; PV, proviolacein; V, violacein. Bold arrows show the modified enzymes. (B-E) 
Model predictions for a test set of 191 unique promoter combinations. The overall Pearson 
correlation coefficient is 0.67 and it is 0.76 for violacein (red), 0.72 for deoxyviolacein (blue), 
0.51 for proviolacein (green) and 0.84 for prodeoxyviolacein (cyan). (F) The expression level 
of VioD is uniquely modified throughout a wide range of one thousand folds experimentally, 
measured to be 0.0013, 0.0174 0.0918,1. (G) HCSA simulation behaves similarly.  
 
Figure 4. Application of HCSA in the genome-scale metabolic network of Saccharomyces 
cerevisiae (A) The yield of biomass components obtained by HCSA correlated well with the 
corresponding coefficient in previous constraint-based model (ݎ = 0.85, ݌ < 4݁ − 13). Red 
dashed line is the fitted line. The expression curves (B) and the flux curves (C) across 
different experiments for all the enzymes in amino acids synthetic pathways. Green and red 
lines are the median curves. (D) The median curve of enzyme expression (green) and the 
coupled amino acids synthetic reaction (red) were merged for comparison. The peak of gene 
expression, a.a. flux and the lowest point of a.a. flux was highlighted by green, red and blue 
drop line respectively.  
 
Figure 5. The sensitivity analysis of the amino acid synthetic network. (A) Metabolic control 
coefficient ߛ௜ = (ݒாୀଵ.ଵ∗ாబ − ݒாୀாబ) ݒாୀଵ.ଵ∗ாబ⁄  at different time points were shown in heat 
map. At each time point (columns, defined by Brar et. al.), at least one reaction was 
rate-limiting. The reactions (rows), like HSDyi/HSDxi/THRA, were rate-limiting in multiple 
conditions (columns). (B) The expression of the enzymes in all the time point was visualized. 
(C) The uptake rate of amino acids at different time point was shown in heat map. The 
down-regulated enzyme expression does not necessarily to be rate-limitting. For instance, 
the down-regulation of phenylalanine synthesis and histidine (red arrows in B) were 
compensated by increasing uptake rate in the late stage of sporulation (green arrows in C).  
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